Zachary Prensky is the founder of LB Pharmaceuticals. LB Pharmaceuticals has raised $130M in total funding. Latest round: Series C. Based in New York, NY.
Zachary Prensky is a co-founder of LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing therapies for neuropsychiatric diseases. He previously served as CEO of LB Pharmaceuticals from 2015 to 2024. Currently, he is the co-founder and CEO of Little Bear Pharmaceuticals, a company focused on developing treatments for orphan neurological disorders. From 1998-2015, he managed a family office that invested in the biotechnology and pharmaceutical sectors.
Full founder directory · Investor directory · Company funding database · Fundraising library